Former Pfizer CEO Kindler joins Lux Capital

Thu Aug 9, 2012 6:27am IST

Stocks

   

Aug 8 (Reuters) - Jeff Kindler, the former chief executive of Pfizer Inc, has joined venture capital firm Lux Capital as a partner, Lux said in a statement, where he will help scout for healthcare investment opportunities and work with portfolio companies.

Kindler retired from Pfizer in December 2010 after eight years with the company and was replaced as CEO by Ian Read.

Apart from his new role at Lux Capital, Kindler also serves on the board of several other pharmaceutical and healthcare companies. He is also a member of U.S. President Barack Obama's management advisory board and a director at private equity firm Starboard Capital Partners.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Diwali Sales

Diwali Sales

Gold sales jump about 20 pct for Diwali - trade body  Full Article 

World Bank Rival

World Bank Rival

Three major nations absent as China launches W.Bank rival in Asia  Full Article 

Wal-Mart India

Wal-Mart India

Murali Lanka appointed as Wal-Mart India operations chief  Full Article 

Microsoft Earnings

Microsoft Earnings

Microsoft sales beat Street hopes, cloud profits up.  Full Article 

Special Report

Special Report

Why Madrid's poor fear Goldman Sachs and Blackstone  Full Article 

U.S. Economy

U.S. Economy

Spectre of no-inflation world looms over Fed's return to normal  Full Article 

Insider Trading

Insider Trading

Rengan Rajaratnam, SEC to settle civil insider trading charge.  Full Article 

Market Watch

Market Watch

Betting on the beaten up? Investors pin hopes on stocks in Europe, Japan.  Full Article 

India Insight

India Insight

Kalki Koechlin on her role as a disabled girl in “Margarita, With a Straw”  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage